Immutep Limited (YP1A STU) stock market data APIs
€1.4467
-0.16(-10%)
as of March 11, 2025
Immutep Limited Financial Data Overview
Prev. Close
1.6049
Open
1.4467
High
1.6049
Low
1.4467
52 wk Range
1.44-3.02
Market Cap
4 902 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Immutep Limited data using free add-ons & libraries
Get Immutep Limited Fundamental Data
Immutep Limited Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Immutep Limited News
New
Immutep Quarterly Activities Report Q2 FY25
Immutep Limited Media Release Marking Immutep’s transition to a Phase III biotech, the Company’s pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regula...
Patient Enrolment Completed for EFTISARC-NEO Phase II Trial
Immutep Limited Phase II trial evaluating efti in combination with radiotherapy plus KEYTRUDA® (pembrolizumab) in patients with soft tissue sarcoma reaches enrolment target of 40 patients Data updat...
Immutep Limited (ASX:IMM) is largely controlled by institutional shareholders who own 51% of the company
Key Insights Institutions' substantial holdings in Immutep implies that they have significant influence over the company's share price The top 7 shareholders own 50% of the company Ownership research...
Patient Enrolment Completed for INSIGHT-003
Immutep Limited Multi-centre trial evaluating efti in combination with pembrolizumab and chemotherapy in patients with non-small cell lung cancer reaches enrolment target of approximately 50 evaluabl...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
